Monday, June 12, 2017

#Cannabis Stock News: CanniMed Therapeutics Inc. (TSX: CMED) Reports Financial Results for Q2 2017

#Cannabis Stock News: CanniMed Therapeutics Inc. (TSX: CMED) Reports Financial Results for Q2 2017

SASKATOON, Saskatchewan - June 12, 2017 ( Newswire) CanniMed Therapeutics Inc. (TSX: CMED) ("CanniMed" or the "Company") today released its financial results for the three and six months ended April 30, 2017.
CanniMed's strong sales momentum continued in the second quarter. Demand for oils has accounted for progressively more of the Company's production, and CanniMed's recently announced oils processing facility is designed to accommodate foreseen growth of this key product group. Recent export sales for pharmacy distribution, together with the Company's arrangements with PharmaChoice and discussions with other Canadian pharmacy chains provide clear indications of future market channels for medical cannabis, and CanniMed is focussed on this expected evolution.

Marijuana / Hemp Stocks

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory

Join our Group on Linkedin - Marijuana / Hemp Stocks - News and Trends in Green Investing

Global Cannabis Investing - features Investor Ideas Cannabis news

Get News Alerts on Marijuana Stocks

Watch the 420 Cannabis Investor video


More Info:

This news is published on the Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info:
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: Global investors must adhere to regulations of each country.

No comments:

Post a Comment